We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.78B
AUM Growth
-$68.3M
Cap. Flow
-$132M
Cap. Flow %
-7.44%
Top 10 Hldgs %
16.28%
Holding
390
New
41
Increased
102
Reduced
174
Closed
34

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.23M
2
ASRT
Assertio
ASRT
+$8.76M
3
ITMN
INTERMUNE INC
ITMN
+$8.58M
4
EPZM
Epizyme, Inc
EPZM
+$8.51M
5
KFRC icon
Kforce
KFRC
+$8.18M

Top Sells

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$40.2M
2
AKRX
Akorn Inc
AKRX
+$21.7M
3
BCOV
Brightcove, Inc.
BCOV
+$10.6M
4
REXX
Rex Energy Corporation
REXX
+$8.91M
5
MTH icon
Meritage Homes
MTH
+$8.41M

Sector Composition

Rank Sector Weight
1 Industrials 17.87%
2 Technology 15.37%
3 Healthcare 14.23%
4 Financials 11.54%
5 Consumer Discretionary 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APA icon
326
APA Corp
APA
$12.8B
$235K 0.01%
2,836
-503
-15% -$41.3K
ELV icon
327
Elevance Health
ELV
$81.9B
$234K 0.01%
2,351
-187
-7% -$16.9K
MS icon
328
Morgan Stanley
MS
$337B
$234K 0.01%
7,493
-3,076
-29% -$95K
MA icon
329
Mastercard
MA
$477B
$232K 0.01%
3,112
-478
-13% -$37.3K
DTV
330
DELISTED
DIRECTV COM STK (DE)
DTV
$232K 0.01%
3,035
-938
-24% -$68.8K
KRFT
331
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$222K 0.01%
+3,958
New +$215K
LMT icon
332
Lockheed Martin
LMT
$134B
$219K 0.01%
1,343
-545
-29% -$85.6K
BLK icon
333
Blackrock
BLK
$164B
$217K 0.01%
689
-55
-7% -$16.8K
MET icon
334
MetLife
MET
$61B
$217K 0.01%
+4,606
New +$212K
DUK icon
335
Duke Energy
DUK
$102B
$215K 0.01%
3,013
-8
-0.3% -$558
BNY
336
Bank of New York Mellon
BNY
$108B
$211K 0.01%
5,965
-964
-14% -$31.8K
EMC
337
DELISTED
EMC CORPORATION
EMC
$211K 0.01%
7,697
-1,639
-18% -$42.6K
NLY icon
338
Annaly Capital Management
NLY
$16.9B
$208K 0.01%
4,738
-378
-7% -$16.3K
BPZ
339
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$207K 0.01%
+64,975
New +$151K
CL icon
340
Colgate-Palmolive
CL
$72.6B
$204K 0.01%
3,142
-251
-7% -$15.8K
GILD icon
341
Gilead Sciences
GILD
$161B
$202K 0.01%
2,848
-592
-17% -$46.4K
OPCH icon
342
Option Care Health
OPCH
$3.4B
$186K 0.01%
6,648
– –
GRT
343
DELISTED
GLIMCHER REALTY TRUST
GRT
$135K 0.01%
13,414
-2,650
-16% -$25K
PGTI
344
DELISTED
PGT, Inc.
PGTI
$124K 0.01%
10,740
– –
BFYT
345
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$121K 0.01%
11,659
-134,917
-92% -$1.52M
PSUN
346
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
$115K 0.01%
38,742
-28,208
-42% -$82.4K
RGLS
347
DELISTED
Regulus Therapeutics
RGLS
$101K 0.01%
+93
New +$103K
GERN icon
348
Geron
GERN
$911M
$92K 0.01%
+46,541
New +$186K
CYNI
349
DELISTED
CYAN INC COM
CYNI
$65K ﹤0.01%
15,240
– –
ETRM
350
DELISTED
EnteroMedics Inc.
ETRM
$63K ﹤0.01%
33
– –
12 13
14
15 16

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Emerald Advisers held 390 positions worth $1.78B, down 3.7% from $1.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Emerald Advisers withdrew a net $132M in Q1 2014, closing 34 positions and reducing 174 holdings. Its most notable exit was Akorn Inc, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Emerald Advisers opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $12.4M.

  • Emerald Advisers's largest Q1 2014 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 817,410 shares worth $12.4M.
  • Emerald Advisers added most to PacWest Bancorp in Q1 2014, an estimated $7.25M increase.
  • Emerald Advisers's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $40.2M.
  • Emerald Advisers fully exited Akorn Inc in Q1 2014, selling an estimated $21.7M.
  • Emerald Advisers's ten largest holdings make up 16% of its $1.78B portfolio in Q1 2014.
  • Emerald Advisers opened 41 new positions and closed 34 in Q1 2014.
  • Emerald Advisers's portfolio value fell 3.7% quarter-over-quarter to $1.78B.

Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.